Latest news with #Belgian-based
Los Angeles Times
14-07-2025
- Automotive
- Los Angeles Times
L.A.'s NantG Power to Provide Batteries for Next-Gen Long Range Windrose EV Semi
NantG Power, a maker of advanced high-performance lithium-ion battery technology, plans to supply its manganese-rich LMFP battery solution to Belgian-based EV Truck maker Windrose Technology, with the goal of increasing the fully loaded range of the Windrose electric sleeper truck to 500 miles with 825 kWh of battery power. NantG Power's technology takes a radically different approach from the widespread lithium iron phosphate (LFP)-based EV batteries used in other vehicles. Adding manganese creates a battery that combines low cost with high performance – as well as high safety. The LMFP battery offers 20% better performance as well as 23% reduction in range loss during col weather. Manganese is readily available as well – it's the 12th most abundant element in Earth's crust and is also a byproduct of steel making. 'At NantG, we bring more than 70 years of combined battery experience and we're committed to marry innovative technology and manufacturing know-how to meet the rapidly growing demand for vastly improved energy density and safety for electric vehicles,' said Dr. Fabio Albano, CTO of NantG, the scientist who created the first solid-state battery prototype in 2007 at the University of Michigan. 'We're excited to work with Windrose because, like us, they are a global innovator across four continents that shares the same commitment in their practical, innovative low-emission truck platform.' Windrose long-haul EV trucks serve North America, Europe, Asia and Oceania. 'Windrose has already proven that an EV truck based on both the LFP and NMC chemistry can be cost effective relative to diesel trucks,' said Wen Han, founder, CEO and chairman. 'However, by deploying NantG Power's innovative manganese-rich battery chemistry, we're going to further improve our truck performance, cost and most importantly, safety' The two companies also are exploring joint manufacturing for this new battery solution in both the United States and the EU. This is a further addition to Windrose's global production strategy in China, Belgium, France and the U.S.
Daily Record
10-06-2025
- Sport
- Daily Record
Matija Frigan to Rangers transfer fee could prove too rich as old pals push the boat out for Croatian hitman
The Westerlo frontman is on Kevin Thelwell's summer shortlist but Hamburg are going all out after return to Bundesliga Rangers could be priced out of a move for Croatian striker Matija Frigan. The Ibrox club have the 22-year-old Westerlo front-man on their transfer radar as new boss Russell Martin lines up new recruits. But Record Sport understands German giants Hamburg are now favourites to land Frigan and are willing to pay around £8.5 million for his services. HSV have just been promoted back to the Bundesliga after a seven-year absence from the top flight and are ready to spend big. Frigan is one of their prime targets, despite interest from Rangers and newly-promoted Premier League outfit Sunderland. New gaffer Martin is in the market for a striker in this summer window and is keen on £4 million Israeli ace Dor Turgeman. According to reports in Croatia, Frigan - who bagged 13 goals for Westerlo last season - is also on his and sporting director Kevin Thelwell 's list of potential targets. But with Hamburg ready to push the boat out for the Belgian-based hit-man, it might be too costly for Rangers - even with fresh investment from their new American owners. Martin is set to revamp his Ibrox squad ahead of the new season and remains keen on signing Leicester City defender Conor Coady. You can get all the news you need on our dedicated Rangers and Celtic pages, and sign up to our newsletters to make sure you never miss a beat throughout the season. We're also on WhatsApp where we bring all the latest breaking news and transfer gossip directly to you phone. Join our Rangers community here and our Celtic community here.
Business Upturn
21-05-2025
- Business
- Business Upturn
SYNDEO Medical Announces ISO 13485 Certification, Expanding Regulatory Portfolio and Supporting Global Growth Strategy
By GlobeNewswire Published on May 21, 2025, 07:33 IST ZAVENTEM, Belgium, May 20, 2025 (GLOBE NEWSWIRE) — SYNDEO Medical, a Belgian-based developer of interventional procedure solutions, is pleased to announce that it has received ISO 13485 certification for its quality management system. This internationally recognised certification adds to SYNDEO Medical's growing portfolio of regulatory approvals and reinforces its continued commitment to quality, compliance, and long-term global growth. The ISO 13485 certification builds on existing MDR approvals for the SYNDEOPack Interventional Procedure Pack™ and the Xssential Rapid Delivery Procedure Pack™, enabling the company to access new clinical markets where ISO 13485 is a regulatory requirement. 'Achieving ISO 13485 is an important milestone that reflects the systems and discipline we've built into our operations,' said A. Justin Lampropoulos, Founder and Chief Executive Officer of SYNDEO Medical. 'From the beginning, we've focused on building something enduring — genuinely grounded in quality, responsiveness, and real-world clinical value.' SYNDEO Medical is highly differentiated in the marketplace by integrating everyday-use diagnostic and interventional products—typically procured separately—into custom-designed interventional procedure packs. This approach simplifies procurement, enhances procedural efficiency, and ensures a more streamlined clinical workflow. 'As we grow, our focus remains on customer-driven innovations that deliver on our brand promise of elevating patient experience, delivering value, and empowering outcomes,' Lampropoulos added. 'ISO 13485 gives us additional confidence as we continue to expand our offering and support our partners in new and existing markets.' About SYNDEO Medical SYNDEO Medical is engaged in the design, development, and distribution of fully integrated custom procedural solution products. Launched in 2023 by A. Justin Lampropoulos and Andrew Cotton and headquartered in Belgium, SYNDEO Medical is dedicated to pushing the boundaries of healthcare innovation. Specialising in minimally invasive interventional and surgical products, SYNDEO Medical serves healthcare providers worldwide through a network of distribution partners and sales representatives. The company is committed to positively impacting lives through elevating patient experience, delivering meaningful value, and empowering outcomes. SYNDEO Medical Public Relations Email: [email protected] An image accompanying this announcement is available at: Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
Yahoo
21-05-2025
- Business
- Yahoo
SYNDEO Medical Announces ISO 13485 Certification, Expanding Regulatory Portfolio and Supporting Global Growth Strategy
ZAVENTEM, Belgium, May 20, 2025 (GLOBE NEWSWIRE) -- SYNDEO Medical, a Belgian-based developer of interventional procedure solutions, is pleased to announce that it has received ISO 13485 certification for its quality management system. This internationally recognised certification adds to SYNDEO Medical's growing portfolio of regulatory approvals and reinforces its continued commitment to quality, compliance, and long-term global growth. The ISO 13485 certification builds on existing MDR approvals for the SYNDEOPack Interventional Procedure Pack™ and the Xssential Rapid Delivery Procedure Pack™, enabling the company to access new clinical markets where ISO 13485 is a regulatory requirement. 'Achieving ISO 13485 is an important milestone that reflects the systems and discipline we've built into our operations,' said A. Justin Lampropoulos, Founder and Chief Executive Officer of SYNDEO Medical. 'From the beginning, we've focused on building something enduring — genuinely grounded in quality, responsiveness, and real-world clinical value.' SYNDEO Medical is highly differentiated in the marketplace by integrating everyday-use diagnostic and interventional products—typically procured separately—into custom-designed interventional procedure packs. This approach simplifies procurement, enhances procedural efficiency, and ensures a more streamlined clinical workflow. 'As we grow, our focus remains on customer-driven innovations that deliver on our brand promise of elevating patient experience, delivering value, and empowering outcomes,' Lampropoulos added. 'ISO 13485 gives us additional confidence as we continue to expand our offering and support our partners in new and existing markets.' About SYNDEO Medical SYNDEO Medical is engaged in the design, development, and distribution of fully integrated custom procedural solution products. Launched in 2023 by A. Justin Lampropoulos and Andrew Cotton and headquartered in Belgium, SYNDEO Medical is dedicated to pushing the boundaries of healthcare innovation. Specialising in minimally invasive interventional and surgical products, SYNDEO Medical serves healthcare providers worldwide through a network of distribution partners and sales representatives. The company is committed to positively impacting lives through elevating patient experience, delivering meaningful value, and empowering outcomes. SYNDEO Medical Public RelationsEmail: trixie@ An image accompanying this announcement is available at: in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Muscat Daily
18-05-2025
- Business
- Muscat Daily
OQGN, Fluxys to develop hydrogen transportation network in Oman
Muscat – OQ Gas Networks (OQGN), the exclusive owner and operator of Oman's natural gas transmission network, announced the signing of a term sheet cooperation agreement with Fluxys, the Belgian-based global energy infrastructure group, to jointly develop the hydrogen transportation infrastructure in Oman, where Fluxys, alongside OQGN, intends to own and operate the hydrogen network as a minority shareholder. OQGN and Fluxys share similar vision in leading energy transition activities, and with complementary infrastructure and aspirations, they are well positioned to enable rapid and efficient development of hydrogen infrastructure to cater to Oman's need in line with Oman's vision 2040 and hydrogen production targets. This cooperation agreement solidifies the partnership between Fluxys and OQGN following the signing in September 2023 of a Memorandum of Understanding (MoU) between the two organisations to strategically collaborate in the hydrogen and CO2 network developments in Oman, as well as Fluxys' acquisition of a 4.9% stake in OQGN as an anchor investor as part of the initial public offering of OQGN. The partnership highlights OQGN's commitment in enabling the timely development of decarbonisation infrastructure in Oman, as well as Fluxys' strategy in connecting and investing in new low-carbon energy value chains with high renewable potential countries to Belgium and Europe and also reflects their intention to exchange knowledge derived from their experiences and prior learnings. The agreement was signed by Eng Mansoor bin Ali al Abdali, OQGN CEO, and Pascal De Buck, Managing Director and CEO of Fluxys, at a ceremony held at the Mandarin Oriental Hotel in Muscat. The event was held under the patronage of H E Salim bin Nasser al Aufi, Minister of Energy and Minerals. In a press statement, Abdali said, 'We are very excited to work with Fluxys in jointly developing the Hydrogen transportation network in Oman, and supporting Oman's green hydrogen and decarbonisation initiatives. This cooperation is a clear signal of our commitment as the national energy infrastructure company in leading the development and deployment of green hydrogen infrastructure to support Oman's energy transition goals and aspirations. Together with Fluxys, we will leverage our considerable joint experience and capabilities meeting Oman's requirements for hydrogen transport infrastructure and realizing the national agenda in a cost-effective manner.' Pascal De Buck added, 'We are delighted to partner with OQGN in developing a new hydrogen transportation network in Oman. As a shareholder of OQGN, this collaboration is a pivotal step in our strategy to accelerating the energy transition and creating new value chains. By harnessing our combined expertise, we aim to bring renewable hydrogen to Belgium and Europe, while also significantly contributing to Oman's sustainable energy goals. Together, we are committed to creating a brighter, greener energy future.'
